Venture Capital Investors

Arch Venture Partners

VC investing group Arch Venture Partners provides capital to innovative high-tech companies.

Venture Investor Overview

Venture Investor
Arch Venture Partners
Status
Active
Investor Type
Venture Capital
Activity Level
398 transactions
Funds Raised
At least $3.4 billion
Industry Focus
AgTech
Biopharmaceutical
Communications
Enterprise IT
Healthcare IT
Healthcare Services
InsureTech
Life Sciences
Medical Devices & Instruments
Software

Contact Information

Contact
Clinton Bybee
Title
Managing Director
Mailing Address
1700 Owens St. 535
San Francisco, CA 94107
USA
Phone
(415) 565-7103
Website
www.archventure.com
Email Address
Not Recorded

Background Information

Overview
Prefers to invest in companies co-founded with leading scientists from academic institutions and national laboratories, and entrepreneurs.
Profile
Arch Venture Partners LinkedIn Company Profile
Social Media
Arch Venture Partners Company Twitter Account
Company News
Arch Venture Partners News
Facebook
Arch Venture Partners on Facebook
YouTube
Arch Venture Partners on YouTube
Last Transaction
4/10/2024

Transaction History

Our records indicate that Arch Venture Partners invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Company
Date
Amount
Seaport Therapeutics
4/10/2024
$100,000,000
Mirador Therapeutics
3/25/2024
$400,000,000
FogPharma
3/1/2024
$145,000,000
Matter Neuroscience
2/26/2024
$26,000,000
Areteia Therapeutics
2/14/2024
$75,000,000
Basking Biosciences
2/1/2024
$55,000,000
Proniras
2/1/2024
$4,650,000
Accompany Health
1/30/2024
$56,000,000
Elephas Biosciences
1/23/2024
$55,000,000
Moonwalk Biosciences
1/4/2024
$57,000,000
HI-Bio
1/4/2024
$95,000,000
Remix Therapeutics
1/3/2024
$60,000,000
Tome Biosciences
12/13/2023
$213,000,000
Gate Bioscience
11/1/2023
$60,000,000
Airna
9/19/2023
$30,000,000
Magnet Biomedicine
9/19/2023
$50,000,000
Generate Biomedicines
9/15/2023
$273,000,000
Rapport Therapeutics
8/23/2023
$150,000,000
Lightcast Discovery
8/18/2023
$49,000,000
Mozart Therapeutics
6/7/2023
$25,000,000
Myeloid Therapeutics
5/18/2023
$73,000,000
Boundless Bio
5/16/2023
$100,000,000
Orbital Therapeutics
4/26/2023
$270,000,000
Recuro Health
4/11/2023
$47,000,000
Volastra Therapeutics
3/7/2023
$60,000,000
Rapport Therapeutics
3/7/2023
$100,000,000
Croma Medicine
3/1/2023
$135,000,000
Chroma Medicine
3/1/2023
$135,000,000
Aera Therapeutics
2/17/2023
$193,000,000
IngredientWerks
2/15/2023
Unknown
Slingshot Biosciences
2/6/2023
$11,000,000
Paradigm
1/31/2023
$203,000,000
Protillion Biosciences
12/19/2022
$18,000,000
Synchron
12/15/2022
$75,000,000
SonoThera
12/5/2022
$60,750,000
FogPharma
11/21/2022
$178,000,000
HI-Bio
11/1/2022
$120,000,000
Human Immunology Biosciences
11/1/2022
$120,000,000
Treeline Biosciences
10/17/2022
$261,300,000
Neumora Therapeutics
10/11/2022
$112,000,000
Rippl Care
9/28/2022
$32,000,000
Pretzel Therapeutics
9/12/2022
$72,500,000
Elephas Biosciences
9/7/2022
$41,500,000
Vilya
8/30/2022
$50,000,000
Happy Health
8/24/2022
$60,000,000
Yoodli
8/8/2022
$6,000,000
Homeward Health
8/3/2022
$50,000,000
Sironax
8/2/2022
$200,000,000
Reserv
7/26/2022
$8,000,000
Vizgen
6/3/2022
$85,200,000
Remix Therapeutics
5/18/2022
$70,000,000
Aspen Neuroscience
5/9/2022
$147,500,000
Pheast Therapeutics
4/26/2022
$76,000,000
TheGuarantors
4/25/2022
$50,000,000
Be Biopharma
4/14/2022
$130,000,000
LifeMine Therapeutics
3/23/2022
$175,000,000
Nutcracker Therapeutics
3/14/2022
$167,000,000
Dewpoint Therapeutics
2/12/2022
$150,000,000
ONI
1/28/2022
$75,000,000
Resilience Bio
11/23/2021
$800,000,000
Generate Biomedicines
11/22/2021
$370,000,000
Arbor Biotechnologies
11/10/2021
$215,000,000
Mozart Therapeutics
10/30/2021
$55,000,000
Cytrellis Biosystems
9/22/2021
$50,000,000
Rome Therapeutics
9/15/2021
$77,000,000
Recuro Health
8/26/2021
$15,000,000
Sonoma Biotherapeutics
8/5/2021
$265,000,000
Slingshot Biosciences
7/23/2021
$23,000,000
Prime Medicine
7/14/2021
$200,000,000
ImmuneID
6/24/2021
$50,000,000
HiberCell
5/20/2021
$67,400,000
Interline Therapeutics
5/14/2021
$92,000,000
Boundless Bio
4/29/2021
$105,000,000
Ultivue
4/28/2021
$50,000,000
Jaguar Gene Therapy
4/14/2021
$139,000,000
Vizgen
4/8/2021
$37,000,000
Volastra Therapeutics
4/7/2021
$12,000,000
insitro
3/16/2021
$400,000,000
eGenesis
3/3/2021
$125,000,000
Vividion Therapeutics
2/25/2021
$135,000,000
ImmuneID
2/18/2021
$17,000,000
Encodia
1/29/2021
$75,000,000
LifeMine Therapeutics
1/8/2021
$50,000,000
Locanabio
12/15/2020
$100,000,000
Remix Therapeutics
12/9/2020
$81,000,000
Resilience Bio
11/24/2020
$800,000,000
Sonoma Biotherapeutics
10/1/2020
$30,000,000
Dewpoint Therapeutics
9/30/2020
$77,000,000
Nutcracker Therapeutics
9/25/2020
$60,000,000
Encoded Therapeutics
7/23/2020
$135,000,000
Glympse Bio
7/17/2020
$46,700,000
Sana Biotechnology
6/29/2020
$700,000,000
Verve Therapeutics
6/12/2020
$63,000,000
Autobahn Therapeutics
6/10/2020
$76,000,000
insitro
5/27/2020
$143,000,000
Mindstrong Health
5/22/2020
$100,000,000
Rome Therapeutics
4/28/2020
$50,000,000
Erasca
4/28/2020
$200,000,000
Aspen Neuroscience
4/2/2020
$70,000,000
Sonoma Biotherapeutics
2/10/2020
$40,000,000
Vizgen
1/31/2020
$14,000,000
EQRx
1/14/2020
$200,000,000
Omniome
1/10/2020
$60,000,000
Epirium
12/19/2019
$85,000,000
Aspen Neuroscience
12/13/2019
$6,500,000
eGenesis
11/8/2019
$100,000,000
Voxel8
10/23/2019
Unknown
Boundless Bio
9/20/2019
$46,400,000
Agrivida
7/26/2019
$8,000,000
Ultivue
6/28/2019
$22,000,000
Encoded Therapeutics
6/27/2019
$104,000,000
BlackThorn Therapeutics
6/14/2019
$76,000,000
Locana
5/23/2019
$55,000,000
LunaPBC
5/9/2019
$4,600,000
Verve Therapeutics
5/8/2019
$58,500,000
Vividion Therapeutics
5/1/2019
$82,000,000
908 Devices
4/30/2019
$17,500,000
Karuna Therapeutics
4/2/2019
$12,000,000
Karuna Therapeutics
3/19/2019
$68,000,000
Beam Therapeutics
3/7/2019
$135,000,000
Erasca
3/6/2019
$18,000,000
Maze Therapeutics
3/1/2019
$191,000,000
HiberCell
2/8/2019
$60,750,000
Glympse Bio
10/10/2018
$22,000,000
KSQ Therapeutics
9/29/2018
$80,000,000
OncoResponse
9/12/2018
$40,000,000
Nebula Genomics
8/30/2018
$4,300,000
Magnolia Neurosciences
8/14/2018
$31,000,000
Karuna Therapeutics
8/3/2018
$42,000,000
Omniome
7/31/2018
$60,000,000
Gossamer Bio
7/24/2018
$230,000,000
AgBiome
7/18/2018
$65,000,000
Mindstrong Health
6/15/2018
$15,000,000
Metacrine
6/8/2018
$65,000,000
Cytrellis Biosystems
6/6/2018
$28,500,000
Brii Biosciences
5/25/2018
$260,000,000
Nohla Therapeutics
5/16/2018
$45,000,000
Beam Therapeutics
5/15/2018
$87,000,000
Luna DNA
5/9/2018
$4,000,000
Proniras
4/30/2018
Unknown
UNITY Biotechnology
3/20/2018
$55,000,000
Ultivue
1/24/2018
$20,000,000
Pioneer Square Labs
1/19/2018
$15,000,000
Gossamer Bio
1/6/2018
$100,000,000
Scholar Rock
1/4/2018
$47,000,000
Metacrine
12/8/2017
$22,000,000
Semma Therapeutics
12/1/2017
$114,000,000
Codiak BioSciences
11/30/2017
$76,500,000
ImmusanT
11/15/2017
$40,000,000
Vir Biotechnology
10/18/2017
$500,000,000
KSQ Therapeutics
10/3/2017
$76,000,000
LifeMine Therapeutics
9/19/2017
$55,000,000
UNITY Biotechnology
8/18/2017
$35,000,000
Homology Medicines
8/2/2017
$83,500,000
Rodeo Therapeutics
7/26/2017
$5,900,000
Mindstrong Health
6/16/2017
$14,000,000
Aira
5/17/2017
$12,000,000
Sienna Biopharmaceuticals
4/26/2017
$40,000,000
eGenesis
3/17/2017
$38,000,000
908 Devices
3/16/2017
$20,000,000
Boragen
3/3/2017
$10,000,000
Grail
3/3/2017
$900,000,000
Vividion Therapeutics
2/3/2017
$50,000,000
ApoGen Biotechnologies
12/13/2016
$7,000,000
Elysium Health
12/7/2016
$20,000,000
Nohla Therapeutics
12/1/2016
$43,500,000
UNITY Biotechnology
10/31/2016
$116,000,000
BlackThorn Therapeutics
10/21/2016
$40,000,000
Carrick Therapeutics
10/4/2016
$95,000,000
Just Biotherapeutics
7/26/2016
$14,000,000
Sienna Biopharmaceuticals
7/13/2016
$12,000,000
Homology Medicines
5/3/2016
$43,500,000
Sienna Biopharmaceuticals
4/30/2016
$34,000,000
Quanterix
3/23/2016
$46,000,000
UNITY Biotechnology
2/4/2016
Unknown
Codiak BioSciences
1/26/2016
$61,000,000
Twist Bioscience
1/19/2016
$61,000,000
Lodo Therapeutics
1/13/2016
$17,000,000
Grail
1/13/2016
$100,000,000
Petra Pharma
1/7/2016
$48,000,000
Scholar Rock
1/4/2016
$36,000,000
Sapphire Energy
12/31/2015
$91,964,000
Codiak BioSciences
11/18/2015
$31,000,000
Aira
10/30/2015
$790,000
Ultivue
10/14/2015
$5,150,000
Just Biotherapeutics
9/22/2015
$15,000,000
AgBiome
8/20/2015
$34,500,000
Metacrine
8/5/2015
$36,000,000
Voxel8
7/24/2015
$12,000,000
Arivale
7/15/2015
$36,000,000
Aledade
6/15/2015
$30,000,000
Twist Bioscience
6/9/2015
$37,000,000
Denali Therapeutics
5/15/2015
$217,000,000
908 Devices
5/6/2015
$11,600,000
Movidius
4/14/2015
$40,000,000
Nanosys
3/31/2015
$5,000,000
Cytrellis Biosystems
3/31/2015
$7,140,000
Semma Therapeutics
3/25/2015
$44,000,000
Chiasma
2/27/2015
$70,000,000
Scholar Rock
9/15/2014
$20,000,000
Juno Therapeutics
8/5/2014
$134,000,000
Twist Bioscience
5/27/2014
$26,000,000
Sorbent Therapeutics
5/15/2014
$6,500,000
Cenexys
3/31/2014
Unknown
Marina Biotech
3/13/2014
$38,000,000
MedVantx
12/31/2013
$2,171,000
Achaogen
12/31/2013
$10,000,000
Juno Therapeutics
12/5/2013
$120,000,000
NextCODE
10/24/2013
$15,000,000
Sage Therapeutics
10/16/2013
$20,000,000
Boreal Genomics
10/7/2013
$18,000,000
FC Therapeutics
9/30/2013
$9,000
Encore Clean Energy
9/30/2013
$1,340,000
Theraclone Sciences
9/30/2013
$4,000,000
Twist Bioscience
9/30/2013
$2,188,000
AgBiome
4/12/2013
$14,500,000
Syros Pharmaceuticals
4/12/2013
$30,000,000
Sorbent Therapeutics
3/31/2013
$2,533,000
BIND Therapeutics
3/31/2013
$8,698,000
Oncofactor
3/31/2013
$273,000
Theraclone Sciences
3/25/2013
$14,000,000
AgInnovation
12/31/2012
$6,500,000
Fate Therapeutics
12/31/2012
$3,358,000
Sapphire Energy
12/31/2012
$2,900,000
Ciespace
12/31/2012
$1,000,000
Quanterix
11/15/2012
$18,500,000
Cambrios Technologies
9/30/2012
$3,929,000
VLST
9/30/2012
$3,372,000
908 Devices
9/6/2012
$8,100,000
Siluria Technologies
7/26/2012
$30,000,000
Chiasma
7/24/2012
$38,500,000
Univa
3/31/2012
$10,386,000
VentiRx Pharmaceuticals
3/31/2012
$6,250,100
Semprius
3/29/2012
$7,500,000
Theraclone Sciences
12/31/2011
$985,200
Ciespace
12/31/2011
$1,006,000
Allozyne
12/23/2011
Unknown
Groove Biopharma
12/12/2011
$6,000,000
Agios Pharmaceuticals
11/17/2011
$78,000,000
Adesto Technologies
10/26/2011
Unknown
Xtera Communications
9/30/2011
$29,430,200
Siluria Technologies
9/27/2011
$20,000,000
Kythera Biopharmaceuticals
9/15/2011
$37,424,989
Theraclone Sciences
9/8/2011
$10,600,000
Shocking Technologies
8/31/2011
$15,200,000
Pulmatrix
8/15/2011
$14,000,000
Sorbent Therapeutics
6/30/2011
$36,000,000
Acylin Therapeutics
6/30/2011
$2,399,900
Semprius
6/29/2011
$20,000,000
Oncofactor
5/25/2011
$2,100,000
bluebird bio
4/20/2011
$30,000,000
Crystal IS
3/31/2011
$2,125,000
Univa
1/26/2011
$7,000,000
Allozyne
12/31/2010
$1,500,200
Acylin Therapeutics
12/31/2010
$1,999,900
Achaogen
12/31/2010
$20,952,300
Kilimanjaro Energy
10/25/2010
Unknown
Siluria Technologies
10/20/2010
$13,300,000
Sapphire Energy
9/30/2010
$5,000,000
MedVantx
9/30/2010
$618,000
Crystal IS
9/30/2010
$2,499,900
Nitronex
9/30/2010
$3,000,000
Achaogen
9/30/2010
$2,232,000
Aveso Displays
9/30/2010
$500,000
Sorbent Therapeutics
9/13/2010
$21,800,000
Ciespace
8/11/2010
$4,000,000
Nanosys
8/10/2010
$25,000,000
XORI
6/30/2010
$2,300,000
Groove Biopharma
4/26/2010
Unknown
Achaogen
4/7/2010
$56,000,000
Shocking Technologies
2/28/2010
$8,000,000
VentiRx Pharmaceuticals
1/12/2010
$25,000,000
InnovaLight
1/6/2010
$18,000,000
Aveso Displays
12/31/2009
$1,300,000
Receptos
11/23/2009
$25,000,000
Fate Therapeutics
11/16/2009
$30,000,000
Cambrios Technologies
11/3/2009
$14,500,000
Pulmatrix
11/2/2009
$30,200,000
Kythera Biopharmaceuticals
9/30/2009
$10,000,000
Univa
9/30/2009
$8,000,000
Allozyne
9/30/2009
$2,663,000
Agios Pharmaceuticals
9/30/2009
$18,000,000
BIND Therapeutics
9/30/2009
$2,246,000
Adesto Technologies
9/3/2009
$14,000,000
Shocking Technologies
8/13/2009
$10,000,000
Limerick BioPharma
7/15/2009
$15,000,000
Surface Logix
6/30/2009
$5,400,000
XORI
6/30/2009
$2,101,800
CoolEdge Lighting
6/30/2009
$482,000
Semprius
6/9/2009
$6,400,000
Elixir Pharmaceuticals
5/19/2009
$12,000,000
Lycera
4/16/2009
$36,000,000
Surface Logix
3/9/2009
$20,000,000
Kythera Biopharmaceuticals
2/18/2009
$10,000,000
Chiasma
1/13/2009
$11,000,000
Qwell Pharmaceuticals
1/6/2009
$7,000,000
PharmSelex
12/31/2008
$4,500,000
Impinj
9/30/2008
$10,578,000
Groove Biopharma
9/30/2008
$3,634,000
Seredigm
9/30/2008
$700,000
Alfalight
9/30/2008
$2,500,000
Recodagen
9/30/2008
$600,000
Quanterix
8/25/2008
$15,000,000
Agios Pharmaceuticals
7/7/2008
$33,000,000
VLST
6/30/2008
$15,000,000
Adesto Technologies
6/30/2008
$5,499,900
Nitronex
6/30/2008
$7,500,000
Chiasma
6/30/2008
$2,896,800
VentiRx Pharmaceuticals
6/30/2008
$13,301,000
Fate Therapeutics
6/30/2008
$12,900,000
Sapphire Energy
5/29/2008
$100,000,000
Kythera Biopharmaceuticals
5/19/2008
$40,000,000
Univa
5/6/2008
Unknown
Apoptos
5/6/2008
$28,000,000
Kotura
2/7/2008
$10,000,000
MediaPHY
2/4/2008
$7,000,000
Sapphire Energy
12/31/2007
$400,000
Aveso Displays
12/31/2007
$2,390,000
Fate Therapeutics
11/29/2007
$12,000,000
BIND Therapeutics
11/27/2007
$16,000,000
Allozyne
10/26/2007
$30,000,000
Elixir Pharmaceuticals
9/30/2007
$28,030,100
Impinj
9/30/2007
$7,000,000
Xtera Communications
8/9/2007
$52,000,000
Accelerator Alumni
8/3/2007
$22,500,000
Sapphire Energy
6/30/2007
$1,025,000
Artificial Muscle
6/5/2007
$20,000,000
Shocking Technologies
4/17/2007
$7,000,000
Semprius
4/16/2007
$4,100,000
Surface Logix
4/4/2007
$20,000,000
Ikaria
3/31/2007
$24,617,000
Cambrios Technologies
3/31/2007
$18,500,000
Sorbent Therapeutics
3/31/2007
$7,800,000
Adesto Technologies
3/31/2007
$6,000,000
Seredigm
3/31/2007
$2,499,900
Ensemble Discovery
3/31/2007
$10,000,100
NeurogesX
3/31/2007
$3,330,000
Theraclone Sciences
3/19/2007
$29,000,000
Ahura Scientific
3/9/2007
$7,000,000
Impinj
3/7/2007
$19,000,000
VentiRx Pharmaceuticals
3/6/2007
$28,900,000
Variation Biotechnologies
1/5/2007
$37,500,000
MedVantx
12/31/2006
$536,000
Elixir Pharmaceuticals
11/29/2006
$46,000,000
Chiasma
11/15/2006
$44,000,000
Achaogen
10/10/2006
$26,000,000
Omeros
9/30/2006
$3,000,000
Aveso Displays
9/30/2006
$6,250,000
Magen BioSciences
8/28/2006
$15,400,000
Kythera Biopharmaceuticals
7/24/2006
$30,000,000
AmberWave
7/20/2006
$25,000,000
Elixir Pharmaceuticals
6/30/2006
$18,400,000
Artificial Muscle
6/30/2006
$875,500
Theraclone Sciences
6/30/2006
$339,000
Celula
6/30/2006
$6,200,000
Nitronex
6/19/2006
$21,800,000
VLST
6/16/2006
$55,000,000
NeurogesX
3/31/2006
$5,065,000
Sorbent Therapeutics
3/31/2006
$19,200,000
Magen BioSciences
3/31/2006
$1,840,000
Theraclone Sciences
3/31/2006
$1,500,000
Ahura Scientific
3/9/2006
$10,000,000
Impinj
12/16/2005
$26,500,000
NeurogesX
12/1/2005
$20,000,000
NanoString Technologies
11/9/2005
$40,000,000
ALIS Technology
9/30/2005
$2,175,000
Kotura
9/7/2005
$13,000,000
Artificial Muscle
8/25/2005
$5,000,000
Univa
8/22/2005
$8,000,000
Alfalight
8/19/2005
$7,000,000
Surface Logix
6/30/2005
$3,999,900
Ensemble Discovery
6/30/2005
$11,020,000
Amphora Discovery
6/30/2005
$9,549,800
Ikaria
6/30/2005
$2,500,000
Xtera Communications
6/30/2005
$2,477,000
Fluensee
6/30/2005
$8,299,800
MedVantx
6/3/2005
$10,500,000
Ceptyr
3/31/2005
$460,000
Trubion Pharmaceuticals
3/31/2005
$12,000,100
ALIS Technology
3/31/2005
$3,500,000
Theraclone Sciences
3/31/2005
$800,000
Confluent Surgical
3/30/2005
$23,000,000
Cambrios Technologies
2/1/2005
$12,000,000
Ahura Scientific
1/19/2005
$10,000,200
Amphora Discovery
12/8/2004
$20,000,000
Accelerator Alumni
11/18/2004
$11,800,000
Crystal IS
9/28/2004
$5,000,000
Vascular Architects
9/3/2004
$11,600,000
Trubion Pharmaceuticals
7/14/2004
$32,000,000
Impinj
7/12/2004
$22,000,000
Ensemble Discovery
5/12/2004
$15,000,000
NeurogesX
2/24/2004
$35,000,000
XenoPort
2/4/2004
$37,000,000
Elixir Pharmaceuticals
10/13/2003
$40,500,000
InfiniCon Systems
9/24/2003
$15,000,000
Medidata Solutions
5/5/2003
$4,000,000
NanoString Technologies
4/24/2003
$30,000,000
Vascular Architects
1/6/2003
$16,000,000

 

Investor Contacts

Title
Name
Email & Social
Managing Director
Kristina Burow
  Kristina Burow LinkedIn Profile  Kristina Burow Twitter Account  Kristina Burow News  Kristina Burow on Facebook
Managing Director
Clinton Bybee
  Clinton Bybee LinkedIn Profile  Clinton Bybee Twitter Account  Clinton Bybee News  Clinton Bybee on Facebook
Managing Director
Keith Crandell
  Keith Crandell LinkedIn Profile  Keith Crandell Twitter Account  Keith Crandell News  Keith Crandell on Facebook
Managing Director
Steven Gillis
  Steven Gillis LinkedIn Profile  Steven Gillis Twitter Account  Steven Gillis News  Steven Gillis on Facebook
Managing Director
Robert Nelsen
  Robert Nelsen LinkedIn Profile  Robert Nelsen Twitter Account  Robert Nelsen News  Robert Nelsen on Facebook
Managing Director
Paul Thurk
  Paul Thurk LinkedIn Profile  Paul Thurk Twitter Account  Paul Thurk News  Paul Thurk on Facebook

 

Funds

Our database includes the following fund closing(s) for Arch Venture Partners. If we are missing funds, please contact us.

Fund Description
Vintage Date
Fund Amount
Arch Venture Fund XI
1/28/2021
$1,850,000,000
ARCH Venture Fund IX
11/18/2016
$408,385,714
ARCH Venture Fund VIII
8/27/2014
$400,000,000
ARCH Venture Fund VII
12/11/2007
$400,000,000
ARCH Venture Fund VI
4/8/2003
$350,000,000

 

Portfolio Companies

Arch Venture Partners has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Tech Company
908 Devices
Accelerator Alumni
Accompany Health
Achaogen
Acylin Therapeutics
Adesto Technologies
Aera Therapeutics
AgBiome
AgInnovation
Agios Pharmaceuticals
Agrivida
Ahura Scientific
Aira
Airna
Aledade
Alfalight
ALIS Technology
Allozyne
AmberWave
Amphora Discovery
ApoGen Biotechnologies
Apoptos
Arbor Biotechnologies
Areteia Therapeutics
Arivale
Artificial Muscle
Aspen Neuroscience
Autobahn Therapeutics
Aveso Displays
Basking Biosciences
Be Biopharma
Beam Therapeutics
BIND Therapeutics
BlackThorn Therapeutics
bluebird bio
Boragen
Boreal Genomics
Boundless Bio
Brii Biosciences
Cambrios Technologies
Carrick Therapeutics
Celula
Cenexys
Ceptyr
Chiasma
Chroma Medicine
Ciespace
Codiak BioSciences
Confluent Surgical
CoolEdge Lighting
Croma Medicine
Crystal IS
Cytrellis Biosystems
Denali Therapeutics
Dewpoint Therapeutics
eGenesis
Elephas Biosciences
Elixir Pharmaceuticals
Elysium Health
Encoded Therapeutics
Encodia
Encore Clean Energy
Ensemble Discovery
Epirium
EQRx
Erasca
Fate Therapeutics
FC Therapeutics
Fluensee
FogPharma
Gate Bioscience
Generate Biomedicines
Glympse Bio
Gossamer Bio
Grail
Groove Biopharma
Happy Health
HI-Bio
HiberCell
Homeward Health
Homology Medicines
Human Immunology Biosciences
Ikaria
ImmuneID
ImmusanT
Impinj
InfiniCon Systems
IngredientWerks
InnovaLight
insitro
Interline Therapeutics
Jaguar Gene Therapy
Juno Therapeutics
Just Biotherapeutics
Karuna Therapeutics
Kilimanjaro Energy
Kotura
KSQ Therapeutics
Kythera Biopharmaceuticals
LifeMine Therapeutics
Lightcast Discovery
Limerick BioPharma
Locana
Locanabio
Lodo Therapeutics
Luna DNA
LunaPBC
Lycera
Magen BioSciences
Magnet Biomedicine
Magnolia Neurosciences
Marina Biotech
Matter Neuroscience
Maze Therapeutics
MediaPHY
Medidata Solutions
MedVantx
Metacrine
Mindstrong Health
Mirador Therapeutics
Moonwalk Biosciences
Movidius
Mozart Therapeutics
Myeloid Therapeutics
NanoString Technologies
Nanosys
Nebula Genomics
Neumora Therapeutics
NeurogesX
NextCODE
Nitronex
Nohla Therapeutics
Nutcracker Therapeutics
Omeros
Omniome
Oncofactor
OncoResponse
ONI
Orbital Therapeutics
Paradigm
Petra Pharma
PharmSelex
Pheast Therapeutics
Pioneer Square Labs
Pretzel Therapeutics
Prime Medicine
Proniras
Protillion Biosciences
Pulmatrix
Quanterix
Qwell Pharmaceuticals
Rapport Therapeutics
Receptos
Recodagen
Recuro Health
Remix Therapeutics
Reserv
Resilience Bio
Rippl Care
Rodeo Therapeutics
Rome Therapeutics
Sage Therapeutics
Sana Biotechnology
Sapphire Energy
Scholar Rock
Seaport Therapeutics
Semma Therapeutics
Semprius
Seredigm
Shocking Technologies
Sienna Biopharmaceuticals
Siluria Technologies
Sironax
Slingshot Biosciences
Sonoma Biotherapeutics
SonoThera
Sorbent Therapeutics
Surface Logix
Synchron
Syros Pharmaceuticals
TheGuarantors
Theraclone Sciences
Tome Biosciences
Treeline Biosciences
Trubion Pharmaceuticals
Twist Bioscience
Ultivue
UNITY Biotechnology
Univa
Variation Biotechnologies
Vascular Architects
VentiRx Pharmaceuticals
Verve Therapeutics
Vilya
Vir Biotechnology
Vividion Therapeutics
Vizgen
VLST
Volastra Therapeutics
Voxel8
XenoPort
XORI
Xtera Communications
Yoodli

 

 

 

 

Browse more venture capital investors:

ARCH Emerging Markets Partners | Arch.Law

 

Share this article

 

About Our VC Investor Database

This venture capital firm data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.